跳至主要内容
临床试验/CTRI/2021/09/036893
CTRI/2021/09/036893招募中未知

Efficacy and Safety of Carvedilol in Cirrhosis Patients With Uncomplicated Ascites Without High Risk Esophageal Varices- A Randomised Controlled Trial.

Institute of Liver and Biliary Sciences0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Age 18-65 years
  • Liver cirrhosis
  • Grade II-III high SAAG ascites
  • Small low risk or no esophageal varices

排除标准

  • Age <18 years
  • AKI at enrollement (Prior transient volume responsive AKI stage I included)
  • Post renal or liver transplantation
  • History of CAD, PVD, ventricular arrythmia, Bronchial asthma
  • SBP at diagnosis
  • Severe Hyponatremia (Na <125 MEq/L)
  • Grade II/III/IV HE
  • Advanced HCC (BCLC C,D), PVTT, Pregnancy or Lactating mother
  • High risk varices (Large varices or small high risk varices)
  • Mixed / TB ascites
  • Bilirubin >5 mg/dl
  • Known CKD, obstructive uropathy
  • Patient on MV, NIV, systemic sepsis and shock
  • Lack of informed consent
  • Prior intolerance or S/E to carvedilol or diuretics

研究者

相似试验